Can antioxidants be effective therapeutics?

Current Opinion in Investigational Drugs

Volumn 11, Issue 4, 2010, Pages 426-431

  Cochemé, Helena M ^a,b   Murphy, Michael P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antioxidant; Oxidative damage; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; GLUTATHIONE; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; THIOREDOXIN; UBIDECARENONE;

ANTIOXIDANT ACTIVITY; CLINICAL ASSESSMENT; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SPECIFICITY; DRUG TARGETING; DRUG UPTAKE; HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW;

ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; RATS;

EID: 77950152255     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. Oxford University Press, Oxford, UK (2007).
2. Winterbourn CC: Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol (2008) 4(5):278-287.
3. Sies H: Strategies of antioxidant defense. Eur J Biochem (1993) 215(2):213-219.
4. Murphy MP: How mitochondria produce reactive oxygen species. Biochem J (2009) 417(1):1-13.
5. Finkel T: Opinion: Radical medicine: Treating ageing to cure disease. Nat Rev Mol Cell Biol (2005) 6(12):971-976.
6. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature (2000) 408(6809):239-247.
7. Balaban RS, Nemoto S, Finkel T: Mitochondria, oxidants, and aging. Cell (2005) 120(4):483-495.
8. Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev (1998) 78(2):547-581.
9. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev (2008) (2):CD007176.
10. Hill MF: Emerging role for antioxidant therapy in protection against diabetic cardiac complications: Experimental and clinical evidence for utilization of classic and new antioxidants. Curr Cardiol Revs (2008) 4(4):259-268.
11. Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA, Perry G: Antioxidant therapy in Alzheimer's disease: Theory and practice. Mini Rev Med Chem (2008) 8(13):1395-1406.
12. Halliwell B: Oxidative stress and neurodegeneration: Where are we now? J Neurochem (2006) 97(6):1634-1658.
13. Pattison DJ, Winyard PG: Dietary antioxidants in inflammatory arthritis: Do they have any role in etiology or therapy? Nat Clin Pract Rheumatol (2008) 4(11):590-596.
14. Pandolfo M: Drug insight: Antioxidant therapy in inherited ataxias. Nat Clin Pract Neurol (2008) 4(2):86-96.
15. Medina J, Moreno-Otero R: Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs (2005) 65(17):2445-2461.
16. Dryden GW Jr, Deaciuc I, Arteel G, McClain CJ: Clinical implications of oxidative stress and antioxidant therapy. Curr Gastroenterol Rep (2005) 7(4):308-316.
17. Block KI: Antioxidants and cancer therapy: Furthering the debate. Integr Cancer Ther (2004) 3(4):342-348.
18. Rinaldi S, Landucci F, De Gaudio AR: Antioxidant therapy in critically septic patients. Curr Drug Targets (2009) 10(9): 872-880.
19. Canter PH, Wider B, Ernst E: The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: A systematic review of randomized clinical trials. Rheumatology (2007) 46(8): 1223-1233.
20. Ueda S, Yasunari K: What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease. Curr Pharm Biotechnol (2006) 7(2):69-72.
21. Jia X, McNeill G, Avenell A: Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials. J Hum Nutr Diet (2008) 21(4):317-336.
22. Qin C, Yap S, Woodman OL: Antioxidants in the prevention of myocardial ischemia/reperfusion injury. Exp Rev Clin Pharmacol (2009) 2(6):673-695.
23. Iannitti T, Palmieri B: Antioxidant therapy effectiveness: An up to date. Eur Rev Med Pharmacol Sci (2009) 13(4):245-278.
24. Diplock AT: Antioxidant nutrients and disease prevention: An overview. Am J Clin Nutr (1991) 53(1 Suppl):189S-193S.
25. Maxwell SR: Prospects for the use of antioxidant therapies. Drugs (1995) 49(3):345-361.
26. Halliwell B, Gutteridge JMC, Cross CE: Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med (1992) 119(6):598-620.
27. Halliwell B, Whiteman M: Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol (2004) 142(2):231-255.
28. Halliwell B: Establishing the significance and optimal intake of dietary antioxidants: The biomarker concept. Nutr Revs (1999) 57(4):104-113.
29. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem (2006) 52(4):601-623.
30. Murphy MP, Smith RA: Drug delivery to mitochondria: The key to mitochondrial medicine. Adv Drug Deliv Rev (2000) 41(2): 235-250.
31. Tyler DD: Polarographic assay and intracellular distribution of superoxide dismutase in rat liver. Biochem J (1975) 147(3): 493-504.
32. Kagan V, Serbinova E, Packer L: Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun (1990) 169(3):851-857.
33. Buettner G: The pecking order of free radicals and antioxidants: Lipid peroxidation, ?-tocopherol, and ascorbate. Arch Biochem Biophys (1993) 300(2):535-543.
34. Ernster L, Forsmark P, Nordenbrand K: The mode of action of lipid-soluble antioxidants in biological membranes: Relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. Bio Factors (1992) 3(4):241-248.
35. Gazis A, White DJ, Page SR, Cockcroft JR: Effect of oral vitamin E (?-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitus. Diabet Med (1999) 16(4): 304-311.
36. Dallner G, Sindelar PJ: Regulation of ubiquinone metabolism. Free Radic Biol Med (2000) 29(3-4):285-294.
37. Ernster L, Dallner G: Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta (1995) 1271(1):195-204.
38. Iqbal J, Hussain MM: Intestinal lipid absorption. Am J Physiol Endocrinol Metab (2009) 296(6):E1183-E1194.
39. Shults CW, Flint Beal M, Song D, Fontaine D: Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp Neurol (2004) 188(2):491-494.
40. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K et al: Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline. Arch Neurol (2002) 59(10): 1541-1550.
41. Matthews RT, Yang L, Browne S, Bail M, Beal MF: Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA (1998) 95(15):8892-8897.
42. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A: Redox-based regulation of signal transduction: Principles, pitfalls, and promises. Free Radic Biol Med (2008) 45(1):1-17.
43. Finkel T: Oxygen radicals and signalling. Curr Opin Cell Biol (1998) 10(2):248-253.
44. Iqbal K, Chohan MO, Grundke-Iqbal I: Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease. J Alzheimer Dis (2008) 15(2): 339-345.
45. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG et al: American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation (2008) 118(14):1497-1518.
46. Riccioni G: Carotenoids and cardiovascular disease. Curr Atheroscler Rep (2009) 11(6):434-439.
47. Briasoulis A, Tousoulis D, Antoniades C, Stefanadis C: The oxidative stress menace to coronary vasculature: Any place for antioxidants? Curr Pharm Design (2009) 15(26):3078-3090.
48. Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN: Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release (2006) 113(3): 189-207.
49. Kern JT, Hannink M, Hess JF: Disruption of the KEAP1- containing ubiquitination complex as an antioxidant therapy. Curr Top Med Chem (2007) 7(10):972-978.